Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

Private Market Index

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Eureka Therapeutics Stock

eurekatherapeutics.comHealthcareFounded: 2006Funding to Date: $52.37MM

Eureka Therapeutics is a biotechnology company focused on breakthrough immunotherapies for the treatment of cancer.

Buy or sell Eureka Therapeutics stock Learn more about Eureka Therapeutics IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Eureka Therapeutics.

Register Today

Team

Management Team

Cheng Liu Ph.D

Founder, President, Chief Executive Officer and Board Member

Jingyi Xiang Ph.D

Head, Bioanalytics

Yiyang Xu Ph.D

Head, Phage display

Vivien Chan Ph.D

Head, Portfolio Management

Board Members

Cheng Liu Ph.D

Hsing-Jien Kung Ph.D

Wai-Yan Chau

Bruce Ames

Peter Lee MD

Wei Zhou Ph.D

Chih-Kai Cheng

Harbinger Venture Management

Michael Cannon

Qiushi Fu

Hsing Kung Ph.D

Acorn Campus Ventures

Other companies like Eureka Therapeutics in the Healthcare sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$809.52MM

Colossal Biosciences

Sector

Last Round Est. Valuation

$1.01B

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Last Round Est. Valuation

$396.01MM

Sector

Sector

Last Round Est. Valuation

$1.53B

Sector

Last Round Est. Valuation

$409.37MM

Frequently Asked Questions